Comparison of sesame cake and cottonseed as supplementary sources of protein to weaned N'Dama bull calves in The Gambia

Summary The potential for increased productivity of N'Dama cattle in response to small supplementary inputs of proteinaceous by-products has been shown to be substantial under village husbandry conditions in The Gambia. Young N'Dama bulls were used to compare sesame cake with cottonseed as sources of supplementary protein during the wet and early dry seasons of 1987. They were fed 0, 40, 80 or 160 g crude protein/day in these forms for four months. Supplementation significantly increased growth rate from 169 g/d in controls to means of 272 and 271 g/d for those given sesame cake and cottonseed respectively; there were no significant differences among the supplemented groups. During the four months of the dry season immediately after supplementation ceased all previously supplemented groups grew significantly more rapidly than the controls (at leastP<0·05), indicating a substantial carry over effect of the supplements. Over this period the mean gain of the groups previously given sesame cake exceeded that of those that had received cottonseed (217 cf. 158 g/d;P<0·01). The economic benefits of these responses were substantial.

---

Comparacion de torta de sesamo y de semilla de algodon como fuente suplementaria de proteina para terneros destetos N'Dama en Gambia

Resumen Se ha demonstrado el potencial para incrementar la productividad del ganado N'Dama, como resquesta a peque?as cantidades de insumos suplementarios de proteína, bajo condiciones de villorrio en Gambia. Se utilizaron terneros destetos N'Dama par comparar la torta de sésamo y de semilla de algodón como fuente de proteína suplementaria durate la estaicón lluviosa y principio de la seca del a?o 1987. Se les dió a los animales 0, 40, 80 o 160 g de proteína cruda/día en éstas formas durante cuatro meses. La suplementación incrementó significativamente la tasa de crecimiento, de 169 g/día en controles a 272 y 271 g/día en aquellos que recibieron torta de sésamo y de algodón respectivamente; no hubo diferenca estadística entre los grupos suplementados. Durate los cuatro meses de la estación seca inmediatamente después de que la suplementación fue suspendida, todos los grupos que habían sido suplementados crecieron sgnificativamente más rápido que los controls (P<0·05), indicando un efecto compensatorio en los suplementados. Durante ese período la media de crecimento de los grupos que recibieron torta de sésamo excedió a aquella de los que habían recibido torta de algodón (217 cf. 158 g/d;P<0·01). Los beneficios económicos de estos resultados fueron substanciales.

---

Comparaison entre le tourteau de sesame et la graine de coton comme sources complementaires de proteines pour les taurillons N'Dama sevres en Gambie

Résumé Le potentiel de réponse à de petites quantités supplémentaires de sous-produits proteiniques pour accroitre la productivité de bétail N'Dama, s'est révélé manifeste, dans les conditions d'élevage villageois en Gambie. De jeunes taureaux N'Dama ont été utilisés pour comparer le tourteau de sésame et la graine de coton en tant que source de complémentation protéinique pendant la saison sèche et le début de la saison humide au cours de l'année 1987. Ils ont re?u respectivement 0, 40, 80 ou 160 g de proteines brutes par jour sus ces deux formes pendat quatre mois. Cette supplémentation a accru de fa?on significative le taux de croissance, de 169 g/jour pour les témoins jusqu'à des moyennes de 272 et 271g/jour respectivement pour ceux qui ont re?u du tourteau de sésame et de la graine de coton. Quant aux groupes complémentés, il n'ont révélé aucune différence significative. Pendat les quatre mois de la saison sèche et immédiatement après l'arrêt de la supplémentation, tous les lots ayant fait précédemment l'objet d'une distribution complémentaire ont eu une croissance significativement plus rapide que les animaux témoins, du moins pourP<0,05, ce qui indique un effet important de report des suppléments. Durant cette période, le gain moyen des lots qui ont re?u le tourteau de sésame a dépassé celui des lots auxquels on a donné de la graine de coton, soit 217 g/jour contre 158 g/jour pourP<0,01. Les profits économiques de ces réponses ont été appréciables.

     

Caprine beta-Mannosidosis in Kids from an Ontario Herd

Caprine β-mannosidosis, a fatal inherited deficiency of the lysosomal enzyme β-mannosidase, was diagnosed in neonatal female Nubian crossbred twin kids from a small herd near Guelph, Ontario. The kids had been tetraplegic since birth, with whole body tremors, abnormal nystagmus and an intention tremor of the head.     

A simple method for isolating leucocytes from bovine blood and their separation into lymphocyte and granulocyte fractions.

A method for the separation of leucocytes from bovine blood and its separation into lymphocyte and granulocyte fractions is described. The method, involving flash lysis of the erythrocyte population, was found to yield large numbers of viable cells suitable for maintenance in tissue culture medium and hence of value in immunological studies.     

Pharmacokinetics of articaine hydrochloride and its metabolite articainic acid after subcutaneous administration in red deer (Cervus elaphus)

AIM: To develop and validate a simple and sensitive method using liquid chromatography-mass spectrometry (LC-MS) for quantification of articaine, and its major metabolite articainic acid, in plasma of red deer (Cervus elaphus), and to investigate the pharmacokinetics of articaine hydrochloride and articainic acid in red deer following S/C administration of articaine hydrochloride as a complete ring block around the antler pedicle.

METHODS: The LC-MS method was validated by determining linearity, sensitivity, recovery, carry-over and repeatability. Articaine hydrochloride (40?mg/mL) was administered S/C to six healthy male red deer, at a dose of 1?mL/cm of pedicle circumference, as a complete ring block around the base of each antler. Blood samples were collected at various times over the following 12 hours. Concentrations in plasma of articaine and articainic acid were quantified using the validated LC-MS method. Pharmacokinetic parameters of articaine and articainic acid were estimated using non-compartmental analysis.

RESULTS: Calibration curves were linear for both articaine and articainic acid. The limits of quantifications for articaine and articainic acid were 5 and 10?ng/mL, respectively. Extraction recoveries were >72% for articaine and >68% for articainic acid. After S/C administration as a ring block around the base of each antler, mean maximum concentrations in plasma (C_max) of articaine were 1,013.9 (SD 510.1) ng/mL, detected at 0.17 (SD 0.00) hours, and the C_max for articainic acid was 762.6 (SD 95.4) ng/mL at 0.50 (SD 0.00) hours. The elimination half-lives of articaine hydrochloride and articainic acid were 1.12 (SD 0.17) and 0.90 (SD 0.07) hours, respectively.

CONCLUSIONS AND CLINICAL RELEVANCE: The LC-MS method used for the quantification of articaine and its metabolite articainic acid in the plasma of red deer was simple, accurate and sensitive. Articaine hydrochloride was rapidly absorbed, hydrolysed to its inactive metabolite articainic acid, and eliminated following S/C administration as a ring block in red deer. These favourable pharmacokinetic properties suggest that articaine hydrochloride should be tested for efficacy as a local anaesthetic in red deer for removal of velvet antlers. Further studies to evaluate the safety and residues of articaine hydrochloride and articainic acid are required before articaine can be recommended for use as a local anaesthetic for this purpose.     

Policies for the vaccination of cats and dogs in New Zealand veterinary practices

AIMS: To determine current practices and attitudes towards vaccination of dogs and cats of veterinarians in New Zealand; the methods used for informing clients on which vaccines to use, and the preferred site for vaccination of cats.

METHODS: A postal questionnaire was sent to all 483 listed veterinary practices in New Zealand during February 2012. Some questions were specific to pet dogs, cats, or working farm dogs. Responses were categorised according to practice type and geographical region of the respondent. Factors associated with respondent recommendation of annual vaccination with modified live viral (MLV) vaccines were examined using logistic regression analysis. Vaccines that were considered to be essential for every animal were defined as core; those that may be recommended for animals whose location or lifestyle placed them at risk, were defined as non-core.

RESULTS: There were 204 useable returns, equivalent to a response rate of 42.2%, distributed across the country. Annual vaccination with MLV vaccines of dogs was recommended by 54/198 (27.3%) respondents, and of cats by 107/181 (59.1%) respondents. Factors associated with the recommendation of annual administration of MLV vaccines to dogs included being a companion animal practice, a desire for policies on vaccination to be left to individual clinics, and having one veterinarian in the practice. Administration of the final vaccination for puppies was recommended at ≥14 weeks old by 55/185 (29.7%) respondents, and for kittens at ≥13 weeks old by 42/183 (23%) respondents. Of respondents that administered MLV vaccines annually, 62/103 (60.2%) believed reducing the frequency of vaccination would reduce income, and 52/103 (50.5%) considered it would have a negative effect on animal health. Advice to enable clients to decide which non-core vaccines were administered was given by 181/199 (91%) respondents. Factors considered when recommending a vaccine included consideration of risk to individual patients (190/203; 93.6%), requirements of boarding kennels/catteries (165/203; 81.3%) and clinic vaccination policy (142/203; 70%). The preferred site for administering MLV vaccines to cats was the dorsal neck or inter-scapular region (137/198; 69.2%). Amongst respondents, 18 wanted disease surveillance information to allow for truly informed decisions to be made about vaccination.

CONCLUSIONS AND CLINICAL RELEVANCE: Veterinarians can now compare their own vaccination practices and attitudes with those of veterinarians nationally, and internationally. There is a need for national surveillance information and for continued education of the public and commercial kennel and cattery owners for optimal vaccination strategies to be developed.     

Effects of the cyclooxygenase inhibitor meloxicam on recovery of ischemia-injured equine jejunum

OBJECTIVE: To determine the effect of meloxicam and flunixin meglumine on recovery of ischemia-injured equine jejunum. ANIMALS: 18 horses. PROCEDURES: Horses received butorphanol tartrate; were treated IV with saline (0.9% NaCl) solution (SS; 12 mL; n = 6), flunixin meglumine (1.1 mg/kg; 6), or meloxicam (0.6 mg/kg; 6) 1 hour before ischemia was induced for 2 hours in a portion of jejunum; and were allowed to recover for 18 hours. Flunixin and SS treatments were repeated after 12 hours; all 3 treatments were administered immediately prior to euthanasia. Selected clinical variables, postoperative pain scores, and meloxicam pharmacokinetic data were evaluated. After euthanasia, assessment of epithelial barrier function, histologic evaluation, and western blot analysis of ischemia-injured and control jejunal mucosa samples from the 3 groups were performed. RESULTS: Meloxicam- or flunixin-treated horses had improved postoperative pain scores and clinical variables, compared with SS-treated horses. Recovery of transepithelial barrier function in ischemia-injured jejunum was inhibited by flunixin but permitted similarly by meloxicam and SS treatments. Eighteen hours after cessation of ischemia, numbers of neutrophils in ischemia-injured tissue were higher in horses treated with meloxicam or flunixin than SS. Plasma meloxicam concentrations were similar to those reported previously, but clearance was slower. Changes in expression of proteins associated with inflammatory responses to ischemic injury and with different drug treatments occurred, suggesting cyclooxygenase-independent effects. CONCLUSIONS AND CLINICAL RELEVANCE: Although further assessment is needed, these data have suggested that IV administration of meloxicam may be a useful alternative to flunixin meglumine for postoperative treatment of horses with colic.